The effect of dienogest and gonadotropin-releasing hormone agonist on pelvic pain after laparoscopic surgery for endometriosis: An RCT
This RCT found that dienogest and GnRH agonists equally reduced pelvic pain in endometriosis patients post-surgery, but caused different adverse effects, notably more vaginal dryness and decreased libido with GnRH agonists.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This randomized controlled trial compared postoperative pelvic pain outcomes after laparoscopic surgery for endometriosis using dienogest versus a gonadotropin-releasing hormone agonist. Participants were followed after surgery to assess pelvic pain as the primary outcome, with the study designed to directly contrast the two hormonal regimens. The main reported result was the relative effect of dienogest and the gonadotropin-releasing hormone agonist on pelvic pain following laparoscopy, with a caveat that the brief provided record does not include effect sizes, follow-up duration, or explicit limitations stated by the authors. This paper is centrally about endometriosis — it evaluates dienogest versus GnRH agonist for pelvic pain after laparoscopic endometriosis surgery.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
1,727 characters
· extracted from
oa-html
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Outcome instruments
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (26)
- A systematic review and Bayesian analysis of the adverse effects of dienogest via openalex
- Clinical efficacy of dienogest against endometriomas with a maximum diameter of ≥4 cm via openalex
- Commentary on the new 2022 European Society of Human Reproduction and Embryology (ESHRE) endometriosis guidelines via openalex
- Comparison of effect of preoperative dienogest and gonadotropin-releasing hormone agonist administration on laparoscopic cystectomy for ovarian endometriomas via openalex
- Co-treatment of gonadotropin and letrozole in infertile women with endometriosis: A double-blind randomized clinical trial via openalex
- Deciding on the appropriate pharmacotherapy for the treatment of endometriosis via openalex
- Dienogest and the Risk of Reoperation in Endometriosis via openalex
- Dienogest compared with gonadotropin‐releasing hormone agonist after conservative surgery for endometriosis via openalex
- Dienogest in the treatment of endometriosis via openalex
- Efficacy and safety of dienogest in the treatment of deep infiltrating endometriosis: A meta-analysis via openalex
- Efficacy of Dienogest on Pelvic Pain and Dyspareunia: Comprehensive Meta-Analysis and Systematic Review via openalex
- Endometrial thickness in the evaluation of clinical response to medical treatment for deep infiltrating endometriosis: a retrospective study via openalex
- GnRH agonists in the treatment of symptomatic endometriosis: a review via openalex
- Gonadotrophin‐releasing hormone analogue or dienogest plus estradiol valerate to prevent pain recurrence after laparoscopic surgery for endometriosis: a multi‐center randomized trial via openalex
- Gonadotropin-releasing hormone analogues for endometriosis via openalex
- Impact of Long-Term Dienogest Therapy on Quality of Life in Asian Women with Endometriosis: the Prospective Non-Interventional Study ENVISIOeN via openalex
- Long-Term Administration of Dienogest for the Treatment of Pain and Intestinal Symptoms in Patients with Rectosigmoid Endometriosis via openalex
- Long-term treatment of endometriosis with dienogest: Real-world results from the VIPOS study via openalex
- Long‐term use of dienogest for the treatment of primary and secondary dysmenorrhea via openalex
- Pelvic Pain, Mental Health and Quality of Life in Adolescents with Endometriosis after Surgery and Dienogest Treatment via openalex
- The Efficacy of Dienogest in Reducing Disease and Pain Recurrence After Endometriosis Surgery: a Systematic Review and Meta-Analysis via openalex
- The Main Theories on the Pathogenesis of Endometriosis via openalex
- Treatment of endometriosis: a review with comparison of 8 guidelines via openalex
- Use of dienogest in endometriosis: a narrative literature review and expert commentary via openalex
- W3194419458 via openalex
- W4309541611 via openalex
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pmc
- last seen: 2026-05-13T20:22:03.195721+00:00
- pubmed
- last seen: 2026-06-04T00:31:52.863761+00:00